These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1532883)

  • 21. Recombinant human erythropoietin and its effects on macro- and microcirculation during normovolemia. A physiological study of hemodynamics, fluid status and skin microcirculation.
    Wirtz JJ; Leunissen KM; van Esser JW; Cheriex EC; Slaaf DW; Reneman RS; van Hooff JP
    Blood Purif; 1990; 8(5):285-94. PubMed ID: 2091688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin (r-HuEPO)].
    Seracini D; Pollini I; Lavoratti GC; Pela I; Materassi M; Danti D; De Simone L; Favilli S; Manetti A
    Pediatr Med Chir; 1994; 16(4):389-92. PubMed ID: 7816703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy.
    Wizemann V; Schäfer R; Kramer W
    Nephron; 1993; 64(2):202-6. PubMed ID: 8321352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients].
    Kinugasa E; Nabeshima K; Niikura K; Kawabe S; Akizawa T; Kitaoka T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1109-16. PubMed ID: 2287103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
    Thanakitcharu P; Siriwiwatanakul N
    J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin.
    Fellner SK; Lang RM; Neumann A; Korcarz C; Borow KM
    Kidney Int; 1993 Dec; 44(6):1309-15. PubMed ID: 8301932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients.
    Cannella G; La Canna G; Sandrini M; Gaggiotti M; Nordio G; Movilli E; Mombelloni S; Visioli O; Maiorca R
    Nephrol Dial Transplant; 1991; 6(1):31-7. PubMed ID: 1829146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin.
    Abdulhadi MH; Fouad-Tarazi FM; Thomas T; Bravo EL; Paganini EP
    Nephrol Dial Transplant; 1990; 5 Suppl 1():102-8. PubMed ID: 2129437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients.
    Tomczak-Watras W; Strózecki P; Zuchora Z; Szefer J; Manitius J
    Pol Arch Med Wewn; 2009; 119(1-2):45-51. PubMed ID: 19341178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of optimized heart failure therapy and anemia correction with epoetin beta on left ventricular mass in hemodialysis patients.
    Hampl H; Hennig L; Rosenberger C; Amirkhalily M; Gogoll L; Riedel E; Scherhag A
    Am J Nephrol; 2005; 25(3):211-20. PubMed ID: 15900093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
    Hino M; Miyazono K; Urabe A; Takaku F
    Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO.
    Hirakata H; Yao H; Osato S; Ibayashi S; Onoyama K; Otsuka M; Ichiya Y; Kuwabara Y; Masuda Y; Fujishima M
    Am J Physiol; 1992 May; 262(5 Pt 2):F737-43. PubMed ID: 1590418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of heart morphology and function following erythropoietin treatment of anemic dialysis patients.
    Sikole A; Polenakovic M; Spirovska V; Polenakovic B; Masin G
    Artif Organs; 1993 Dec; 17(12):977-84. PubMed ID: 8110072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of recombinant human erythropoietin (r-HuEPO) on left ventricular mass and left ventricular hemodynamics in hemodialysis patients.
    Minagawa T; Hirano T; Takada N; Ishiguro M; Ohtsuka H
    Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):934-41. PubMed ID: 7933670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin.
    Ueki Y; Nagata M; Miyake S; Tominaga Y
    J Clin Immunol; 1993 Jul; 13(4):279-87. PubMed ID: 7901232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
    Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of erythropoietin treatment on thyroid dysfunction in hemodialysis patients with renal anemia.
    Tomoda F; Takata M; Izumino K; Oh-hashi S; Ueno H; Iida H
    Nephron; 1994; 66(3):307-11. PubMed ID: 8190183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin.
    Macdougall IC; Lewis NP; Saunders MJ; Cochlin DL; Davies ME; Hutton RD; Fox KA; Coles GA; Williams JD
    Lancet; 1990 Mar; 335(8688):489-93. PubMed ID: 1968526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
    Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE
    Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.